Search Results - "Cossette, Travis"
-
1
Enhancing face validity of mouse models of Alzheimer's disease with natural genetic variation
Published in PLoS genetics (31-05-2019)“…Classical laboratory strains show limited genetic diversity and do not harness natural genetic variation. Mouse models relevant to Alzheimer's disease (AD)…”
Get full text
Journal Article -
2
Long-term Correction of Very Long-chain Acyl-CoA Dehydrogenase Deficiency in Mice Using AAV9 Gene Therapy
Published in Molecular therapy (01-06-2012)“…Very long-chain acyl-coA dehydrogenase (VLCAD) is the rate-limiting step in mitochondrial fatty acid oxidation. VLCAD-deficient mice and patients clinical…”
Get full text
Journal Article -
3
In vivo post-transcriptional gene silencing of α-1 antitrypsin by adeno-associated virus vectors expressing siRNA
Published in Laboratory investigation (01-09-2007)“…α-1 Antitrypsin (AAT) deficiency is one of the most common genetic diseases in North America, with a carrier frequency of approximately 4% in the US…”
Get full text
Journal Article -
4
Model‐EyeD: Harnessing the potential of the eye as a biomarker for Alzheimer’s disease and related dementias
Published in Alzheimer's & dementia (01-12-2023)“…Background Disease‐modifying treatments for Alzheimer’s disease and related dementias (ADRD) will be most effective early in the disease process. Clinical use…”
Get full text
Journal Article -
5
Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa
Published in Human gene therapy (01-09-2015)“…Our collaborative successful gene replacement therapy using AAV vectors expressing a variant of human RPGR-ORF15 in two canine models provided therapeutic…”
Get more information
Journal Article -
6
Long-term preservation of cone photoreceptors and restoration of cone function by gene therapy in the guanylate cyclase-1 knockout (GC1KO) mouse
Published in Investigative ophthalmology & visual science (01-09-2011)“…The authors previously showed that subretinal delivery of AAV5 vectors containing murine guanylate cyclase-1 (GC1) cDNA driven by either photoreceptor-specific…”
Get full text
Journal Article -
7
Dynamic bioinspired coculture model for probing ER + breast cancer dormancy in the bone marrow niche
Published in Science advances (10-03-2023)“…Late recurrences of breast cancer are hypothesized to arise from disseminated tumor cells (DTCs) that reactivate after dormancy and occur most frequently with…”
Get full text
Journal Article -
8
GENETICALLY DIVERSE MOUSE MODELS OF ALZHEIMER’S DISEASE EXHIBIT DIFFERENTIAL MYELOID CELL RESPONSE AND NEURODEGENERATION
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article -
9
O1‐01‐03: GENETICALLY DIVERSE MOUSE MODELS OF ALZHEIMER'S DISEASE EXHIBIT DIFFERENTIAL MYELOID CELL RESPONSE AND NEURODEGENERATION
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article -
10
Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa
Published in Human gene therapy. Clinical development (01-03-2013)“…Abstract Proof of concept for MERTK gene replacement therapy has been demonstrated using different viral vectors in the Royal College of Surgeon (RCS) rat, a…”
Get more information
Journal Article -
11
Recombinant AAV Serotype and Capsid Mutant Comparison for Pulmonary Gene Transfer of α-1-Antitrypsin Using Invasive and Noninvasive Delivery
Published in Molecular therapy (01-01-2009)“…Recombinant adeno-associated viral (rAAV) vectors have been widely used in pulmonary gene therapy research. In this study, we evaluated the transduction and…”
Get full text
Journal Article -
12
Biodistribution and toxicology studies of AAV2/rh8-CBA- beta -hexosaminidase after intracranial delivery in C57/BI6 mice
Published in Molecular therapy (01-09-2013)“…Tay-Sachs disease (TSD) is an autosomal recessive neurodegenerative disease resulting from a lack of functional lysosomal enzyme [Beta]-N-acetylhexosaminidase…”
Get full text
Journal Article -
13
Efficient Hepatic Delivery and Expression from a Recombinant Adeno-associated Virus 8 Pseudotyped α1-Antitrypsin Vector
Published in Molecular therapy (01-11-2005)Get full text
Journal Article -
14
Long-term Correction of Very Long-chain Acyl-CoA Dehydrogenase Deficiency in Mice Using AAV9 Gene Therapy
Published in Molecular therapy (01-06-2012)Get full text
Journal Article -
15
Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid α-glucosidase
Published in Human gene therapy. Clinical development (01-09-2013)“…A biodistribution and toxicology study was performed to test the acute toxicities of intradiaphragmatic injection of a recombinant adeno-associated virus…”
Get more information
Journal Article -
16
Glycogen Storage Disease Type Ia in Canines : A Model for Human Metabolic and Genetic Liver Disease
Published in Journal of biomedicine & biotechnology (01-01-2011)“…A canine model of Glycogen storage disease type Ia (GSDIa) is described. Affected dogs are homozygous for a previously described M121I mutation resulting in a…”
Get full text
Journal Article -
17
Recombinant AAV Serotype and Capsid Mutant Comparison for Pulmonary Gene Transfer of [alpha]-1-Antitrypsin Using Invasive and Noninvasive Delivery
Published in Molecular therapy (01-01-2009)“…Recombinant adeno-associated viral (rAAV) vectors have been widely used in pulmonary gene therapy research. In this study, we evaluated the transduction and…”
Get full text
Journal Article -
18
Systemic correction of a fatty acid oxidation defect by intramuscular injection of a recombinant adeno-associated virus vector
Published in Human gene therapy (01-01-2006)“…Mitochondrial beta-oxidation of fatty acids is required to meet physiologic energy requirements during illness and periods of fasting or physiologic stress,…”
Get more information
Journal Article -
19
In vivo post-transcriptional gene silencing of [alpha]-1 antitrypsin by adeno-associated virus vectors expressing siRNA
Published in Laboratory investigation (01-09-2007)“…alpha-1 Antitrypsin (AAT) deficiency is one of the most common genetic diseases in North America, with a carrier frequency of approximately 4% in the US…”
Get full text
Journal Article -
20
Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector
Published in Molecular therapy (01-11-2005)“…alpha1-Antitrypsin (AAT) deficiency is a single-gene disorder in which a mutation in the AAT (approved symbol SERPINA1) gene (PI*Z) leads to misfolding of the…”
Get full text
Journal Article